Patient with mCRPC and Hepatic Disease

EP: 1.Bone Predominant mCRPC Patient Case

EP: 2.Case 1: A 68-Year-Old Man with Bone-Predominant Metastatic Castration-Resistant Prostate Cancer (mCRPC)

EP: 3.Abiraterone Acetate Versions for Treatment of mCRPC

EP: 4.Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC

EP: 5.Assessing Treatment Efficacy: Communication with Patients and Caregivers

Now Viewing

EP: 6.Patient with mCRPC and Hepatic Disease

Video content above is prompted by the following:

• How often do you see patients with mCRPC and hepatic dysfunction?
• Are there any additional tests you would order for this patient?
• What treatments would you consider for this patient?